Showing results (71-80 of 162) with videos related to
Sort By:
Pageof 17
Aktuelle Urologie|September 18, 2013
[Carcinoma of the pararenal gland infiltrating the surrounding tissue and involving the inferior vena cava]J Dillner, F Meyer, H Lippert, et al.The Journal of Infectious Diseases|May 1, 1990
Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosisA Linde, B Kallin, J Dillner, et al.Sexually Transmitted Diseases|September 15, 2000
Seropositivity to multiple sexually transmitted infections is not commonM Kibur, P Koskela, J Dillner, et al.Journal of Virology|December 1, 1987
Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell linesJ Finke, M Rowe, B Kallin, et al.International Immunology|April 1, 1995
HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1G Stuber, J Dillner, S Modrow, et al.American Journal of Obstetrics and Gynecology|March 1, 1996
Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigensK Elfgren, P Bistoletti, L Dillner, et al.Journal of Medical Microbiology|May 8, 2001
Poor antibody response against human papillomavirus in adult-onset laryngeal papillomatosisL-M Aaltonen, E Auvinen, J Dillner, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 22, 2001
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fractionM Lehtinen, T Luukkaala, K L Wallin, et al.Immunology Letters|August 1, 1988
Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP)D Sulitzeanu, R Szigeti, A Hatzubai, et al.Vaccine|August 12, 2008
Seroepidemiology as basis for design of a human papillomavirus vaccination programJ Ryding, K M French, P Naucler, et al.Pageof 17